Rapha Capital Management, a Florida-based venture fund founded in 2017, specializes in investing in early-stage biotechnology companies in the healthcare and life science sectors. The fund, managed by Partner Kevin M. Slawin, focuses on funding startups at various stages including Pre-Seed, Seed, Series A, and Series B. With a total of 5 investments and 2 exits to date, Rapha Capital Management actively seeks opportunities to support innovative biotech ventures. For more information, visit their website at raphacap.com or contact Partner Kevin M. Slawin via email at kslawin@poncetherapeutics.com.